Abstract:Chronic constipation is a multi-symptomatic, multifactorial, and heterogeneous gastrointestinal disorder. Current pharmacological treatments for chronic constipation are limited and might negatively impact the patients' quality of life. Although probiotics have been shown to improve constipation symptoms, their specific regulatory mechanisms remain unclear. This study sought to explore how probiotic complexes may affect chronic constipation by improving patients' defecation habits. Furthermore, microbial profiles and non-targeted metabolites were assessed to explore the metabolic pathways involved in the improvement of constipation by probiotics. Patients with chronic constipation were treated using a single-blind, randomised, placebo-controlled trial design. The experimental group was administered Lactobacillus powder prepared from 15 probiotic products, and maltodextrin was used as a placebo. Samples were collected twice daily for 4 weeks, and faecal samples were analysed using 16S rRNA sequencing and untargeted metabolic histology. Probiotic treatment changed the makeup of the gut microbiota, enhanced the quantity of Bifidobacterium and Lactobacillus, and markedly reduced clinical symptoms. The 16S rRNA analysis revealed that the abundance of Bifidobacterium and Prevotella increased while that of Thickettsia declined. Moreover, there was a decrease in the abundance of Faecalibacterium and Roseburia. Non-targeted metabolomics analysis identified several differential metabolites, including succinic acid, fumaric acid, cholesterol, xanthurenic acid, 3-alpha,7-alpha-trihydroxy-5beta-cholestan-26-oic, and N-methyltryptamine. KEGG analysis showed that these metabolites were mainly associated with metabolic pathways such as primary bile acid biosynthesis, tryptophan metabolism, alanine, aspartate and glutamate metabolism, phenylalanine metabolism, cholesterol metabolism, and propanoate metabolism. In this study, gut microbiome and non-targeted metabolome analyses were performed on collected faecal samples to compare characteristic microorganisms and differential metabolites to provide new insights and references for probiotic intervention in constipation. Trial registered at chictr.org.cn under number: ChiCTR2200056274.

The edible <i>Lactobacillus paracasei</i> X11 with Konjac glucomannan promotes intestinal motility in zebrafish

The edible Lactobacillus paracasei X11 with Konjac glucomannan promotes intestinal motility in zebrafish

Screening of Novel Probiotics with Intestinal Peristalsis-Promoting Potential Based on in Vitro and in Vivo Investigations

Combination of Galacto-Oligosaccharides and Wheat Peptides Synergistically Relieved Constipation Via Regulating Water Transport, Gut Barrier, Inflammation and Gut Microbiota

Screening of intestinal peristalsis-promoting probiotics based on a zebrafish model.

Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by <i>Ligilactobacillus salivarius</i> Li01

Synergistic Effects of Ligilactobacillus Salivarius Li01 and Psyllium Husk Prevent Mice from Developing Loperamide-Induced Constipation

Ligilactobacillus acidipiscis YJ5 modulates the gut microbiota and produces beneficial metabolites to relieve constipation by enhancing the mucosal barrier

Effect of Konjac Glucomannan on Metabolites in the Stomach, Small Intestine and Large Intestine of Constipated Mice and Prediction of the KEGG Pathway

Positive Enhancement of Lactobacillus Fermentum HY01 on Intestinal Movements of Mice Having Constipation

Prevention of loperamide induced constipation in mice by KGM and the mechanisms of different gastrointestinal tract microbiota regulation

Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder

The Probiotic Fermented Milk of Lacticaseibacillus Paracasei JY062 and Lactobacillus Gasseri JM1 Alleviates Constipation Via Improving Gastrointestinal Motility and Gut Microbiota.

The Probiotic Combination of Lacticaseibacillus Paracasei JY062 and Lactobacillus Gasseri JM1 Alleviates Gastrointestinal Motility Disorder Via Improving Gut Microbiota

Lactobacillus paracasei Relieves Constipation by Acting on the Acetic Acid-5-HT-Intestinal Motility Pathway

Efficacy of Probiotic Compounds in Relieving Constipation and Their Colonization in Gut Microbiota

Study of gastrointestinal tract viability and motility via modulation of serotonin in a zebrafish model by probiotics.

Effects of Lactiplantibacillus plantarum GUANKE on Diphenoxylate-Induced Slow Transit Constipation and Gut Microbiota in Mice

Different microbial ecological agents change the composition of intestinal microbiota and the levels of SCFAs in mice to alleviate loperamide-induced constipation

Mechanisms underlying the promotion of 5-hydroxytryptamine secretion in enterochromaffin cells of constipation mice by <i>Bifidobacterium</i> and <i>Lactobacillus</i>

Effects of complex probiotics on intestinal function and its regulatory mechanism in patients with constipation